Condition category
Cancer
Date applied
30/09/2005
Date assigned
30/09/2005
Last edited
26/10/2015
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Prof Andrew K Burroughs

ORCID ID

Contact details

Department of Liver Medicine & Transplantation
Royal Free Hampstead NHS Trust
Pond Street
Hampstead
London
NW3 2QG
United Kingdom

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

N0256159469

Study information

Scientific title

A randomised parallel group study to compare transarterial particle embolism with percutaneous ethanol injection in patients with unifocal, small (<3cm), non-resectable hepatocellular carcinoma

Acronym

Study hypothesis

Which is the best treatment in terms of survival of patients diagnosed with unresectable unifocal hepatocellular carcinoma (HCC) less than 3 cm in diameter treated with percutaneous ethanol injection or transarterial particle embolisation?

Ethics approval

Not provided at time of registration

Study design

Randomised parallel-group study

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Hospitals

Trial type

Treatment

Patient information sheet

Not available in web format, please use the contact details below to request a patient information sheet

Condition

Cancer: Liver

Intervention

Percutaneous ethanol injection or transarterial particle embolisation

Intervention type

Drug

Phase

Not Applicable

Drug names

Ethanol

Primary outcome measures

Survival of patient after treatment of unresectable, unifocal, small (3 cm) hepatocellular carcinoma

Secondary outcome measures

Not provided at time of registration

Overall trial start date

31/07/2003

Overall trial end date

31/07/2006

Reason abandoned

Eligibility

Participant inclusion criteria

Not provided at time of registration

Participant type

Patient

Age group

Not Specified

Gender

Not Specified

Target number of participants

185

Participant exclusion criteria

Not provided at time of registration

Recruitment start date

31/07/2003

Recruitment end date

31/07/2006

Locations

Countries of recruitment

United Kingdom

Trial participating centre

Royal Free Hampstead NHS Trust
London
NW3 2QG
United Kingdom

Sponsor information

Organisation

Department of Health

Sponsor details

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
+44 (0)20 7307 2622
dhmail@doh.gsi.org.uk

Sponsor type

Government

Website

http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

Funder name

The Royal Free Hampstead NHS Trust (UK)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Funder name

NHS R&D Support Funding

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes